Lysophosphatidic acid receptor 1 influences disease severity in a mouse model of multiple sclerosis
Uemura, N.; Matsuo, N.; Taniyama, K.; Nakajima, H.; Nagayasu, K.; Kaneko, S.; Chun, J.; Ueda, H.; Shirakawa, H.
Show abstract
Multiple sclerosis (MS), a chronic inflammatory disease affecting the central nervous system (CNS), is characterized by demyelination and axonal degeneration. Current treatments, which focus mainly on reducing lymphocyte infiltration into the CNS, are insufficient due to serious side effects and limited effectiveness; thus, identifying drugs with new mechanisms of action is crucial. Lysophosphatidic acid (LPA), a bioactive lipid produced by the enzyme autotaxin, may play a role in MS pathogenesis. Specifically, the LPA1 subtype of LPA receptors is linked to release of inflammatory cytokines in the CNS, and to demyelination in the peripheral nervous system. Our study investigated the role of LPA1 in a mouse model of MS. Knocking out the LPA1 gene in mice with experimental autoimmune encephalomyelitis improved clinical outcomes and reduced demyelination. Additionally, the absence of LPA1 reduced activation of Iba1-positive cells. Treatment with AM095, an LPA1 antagonist, tended to improve clinical outcomes and reduce levels of inflammatory mediators. These findings indicate that activation of LPA1 contributes to MS pathogenesis by promoting microglial activation and infiltration of peripheral immune cells.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Genetic deletion of Autotaxin from CD11b+ cells decreases the severity of experimental autoimmune encephalomyelitis 97%
- Priming of Myelin-Specific T Cells in the Absence of Dendritic Cells Results in Accelerated Development of Experimental Autoimmune Encephalomyelitis 96%
- Masitinib Limits Neuronal Damage, as Measured by Serum Neurofilament Light Chain Concentration, in a Model of Neuroimmune-Driven Neurodegenerative Disease 96%
Similar papers in this journal
- Activation of macrophages by lysophosphatidic acid through the lysophosphatidic acid receptor 1 as a novel mechanism in multiple sclerosis pathogenesis. 96%
- Absence of receptor for advanced glycation end product (RAGE) reduces inflammation and extends survival in the hSOD1G93A mouse model of amyotrophic lateral sclerosis 95%
- Leukocyte telomere length in patients with multiple sclerosis and its association with clinical phenotypes 94%
Similar papers in this journal
- Dynamics of central remyelination and treatment evolution in a model of Multiple Sclerosis with Optic Coherence Tomography 96%
- Profiling blood-based neural biomarkers and cytokines in experimental autoimmune encephalomyelitis model of multiple sclerosis using single molecule array technology 96%
- Gene expression and alternative splicing analysis in a large-scale Multiple Sclerosis study 95%
Similar papers in this journal
- Spontaneous human CD8 T cell and EAE-inducible human CD4/CD8 T cell lesions in the brain and spinal cord of HLA-DRB1*15-positive multiple sclerosis PBMC humanized mice 95%
- In Vivo MRI of Endogenous Remyelination in a Nonhuman Primate Model of Multiple Sclerosis 94%
- Single-cell profiling reveals periventricular CD56bright NK cell accumulation in multiple sclerosis 93%
Similar papers in this journal
- Peripheral Myeloid-Derived Suppressor Cells are good biomarkers of the efficacy of Fingolimod in Multiple Sclerosis 97%
- Senolytic treatment depletes microglia and decreases severity of experimental autoimmune encephalomyelitis. 95%
- RGS10 Attenuates Systemic Immune Dysregulation Induced by Chronic Inflammatory Stress 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.